Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1998;7(6):373–380. doi: 10.1080/09629359890749

The role of selective cyclooxygenase isoforms in human intestinal smooth muscle cell stimulated prostanoid formation and proliferation.

W E Longo 1, B Erickson 1, N Panesar 1, J E Mazuski 1, S Robinson 1, D L Kaminski 1
PMCID: PMC1781872  PMID: 9927229

Abstract

Intestinal smooth muscle plays a major role in the repair of injured intestine and contributes to the prostanoid pool during intestinal inflammatory states. Cyclooxygenase (COX), which catalyzes the conversion of arachidonic acid to prostanoids exists in two isoforms, COX-1 and COX-2. The purpose of this study was to determine the relative contributions of COX-1 and COX-2 in the production of prostanoids by human intestinal smooth muscle (HISM) cells when stimulated by interleukin-1beta (IL-1beta) and lipopolysaccharide (LPS). Furthermore the effects of specific COX-1 and COX-2 inhibitors on the proliferation of smooth muscle cells was also evaluated. Confluent monolayer cultures of HISM cells were incubated with IL-1beta or LPS for 0-24h while control cells received medium alone. PGE2 and PGI2 as 6-keto-PGF1alpha and LTB4 were measured by a specific radioimmunoassay. COX enzymes were evaluated by Western immunoblotting. Unstimulated and stimulated cells were exposed to the specific COX-1 inhibitor valerylsalicylic acid (VSA) and the COX-2 inhibitors NS-398 and SC-58125. The effects of serum on proliferation were then evaluated in the presence of each of the specific COX inhibitors by incorporation of 3H-thymidine into DNA. IL-1beta and LPS increased both PGE2 and 6-keto-PGF1alpha in a dose dependent fashion with enhanced production detected two hours following exposure. Neither stimulus stimulated LTB4 release. Immunoblot analysis using isoform-specific antibodies showed that both COX-1 and COX-2 were present constitutively. Furthermore, COX-1 was upregulated by each inflammatory stimulus. In a separate set of experiments cells were pretreated with either the selective COX-1 inhibitor VSA or the selective COX-2 inhibitors NS-398 or SC-58125 prior to treatment with IL-1beta or LPS. The COX-1 and COX-2 inhibitors decreased both basal and IL-1beta and LPS stimulated prostanoid release. Spontaneous DNA synthesis was present and serum consistently increased proliferation. 3H-thymidine incorporation, stimulated by serum, was inhibited by both COX-1 and COX-2 inhibitors. This study suggests that the prostanoid response stimulated by proinflammatory agents of gut-derived smooth muscle cells appears to be mediated by both COX-1 and COX-2 enzymes. Proliferation of smooth muscles cells also appears to be influenced by both COX-1 and COX-2.

Full Text

The Full Text of this article is available as a PDF (249.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  2. Coffey R. J., Hawkey C. J., Damstrup L., Graves-Deal R., Daniel V. C., Dempsey P. J., Chinery R., Kirkland S. C., DuBois R. N., Jetton T. L. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):657–662. doi: 10.1073/pnas.94.2.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dong Y. L., Gangula P. R., Fang L., Yallampalli C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins. 1996 Jul;52(1):13–34. doi: 10.1016/0090-6980(96)00059-7. [DOI] [PubMed] [Google Scholar]
  4. Gould S. R., Brash A. R., Conolly M. E., Lennard-Jones J. E. Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Med. 1981 Feb;6(2):165–182. doi: 10.1016/0161-4630(81)90088-4. [DOI] [PubMed] [Google Scholar]
  5. Graham M. F., Willey A., Adams J., Yager D., Diegelmann R. F. Interleukin 1 beta down-regulates collagen and augments collagenase expression in human intestinal smooth muscle cells. Gastroenterology. 1996 Feb;110(2):344–350. doi: 10.1053/gast.1996.v110.pm8566579. [DOI] [PubMed] [Google Scholar]
  6. Graham M. F., Willey A., Zhu Y. N., Yager D. R., Sugerman H. J., Diegelmann R. F. Corticosteroids repress the interleukin 1 beta-induced secretion of collagenase in human intestinal smooth muscle cells. Gastroenterology. 1997 Dec;113(6):1924–1929. doi: 10.1016/s0016-5085(97)70012-x. [DOI] [PubMed] [Google Scholar]
  7. Herschman H. R. Prostaglandin synthase 2. Biochim Biophys Acta. 1996 Jan 5;1299(1):125–140. doi: 10.1016/0005-2760(95)00194-8. [DOI] [PubMed] [Google Scholar]
  8. Longo W. E., Damore L. J., Mazuski J. E., Smith G. S., Panesar N., Kaminski D. L. The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation. Mediators Inflamm. 1998;7(2):85–91. doi: 10.1080/09629359891225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Owens M. W., Grisham M. B. Cytokines increase proliferation of human intestinal smooth muscle cells: possible role in inflammation-induced stricture formation. Inflammation. 1993 Aug;17(4):481–487. doi: 10.1007/BF00916587. [DOI] [PubMed] [Google Scholar]
  10. Pang L., Knox A. J. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells. Br J Pharmacol. 1997 Jun;121(3):579–587. doi: 10.1038/sj.bjp.0701152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pritchard K. A., Jr, O'Banion M. K., Miano J. M., Vlasic N., Bhatia U. G., Young D. A., Stemerman M. B. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem. 1994 Mar 18;269(11):8504–8509. [PubMed] [Google Scholar]
  12. Reuter B. K., Asfaha S., Buret A., Sharkey K. A., Wallace J. L. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest. 1996 Nov 1;98(9):2076–2085. doi: 10.1172/JCI119013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rich G., Yoder E. J., Prokuski L., Moore S. A. Prostaglandin production in cultured cerebral microvascular smooth muscle is serum dependent. Am J Physiol. 1996 May;270(5 Pt 1):C1379–C1387. doi: 10.1152/ajpcell.1996.270.5.C1379. [DOI] [PubMed] [Google Scholar]
  14. Sheng G. G., Shao J., Sheng H., Hooton E. B., Isakson P. C., Morrow J. D., Coffey R. J., Jr, DuBois R. N., Beauchamp R. D. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Gastroenterology. 1997 Dec;113(6):1883–1891. doi: 10.1016/s0016-5085(97)70007-6. [DOI] [PubMed] [Google Scholar]
  15. Sheng H., Shao J., Kirkland S. C., Isakson P., Coffey R. J., Morrow J., Beauchamp R. D., DuBois R. N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest. 1997 May 1;99(9):2254–2259. doi: 10.1172/JCI119400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Smith W. L., Marnett L. J. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta. 1991 Apr 24;1083(1):1–17. doi: 10.1016/0005-2760(91)90119-3. [DOI] [PubMed] [Google Scholar]
  17. Stratton M. D., Sexe R., Peterson B., Kaminski D. L., Li A. P., Longo W. E. The effect of trinitrobenzene sulfonic acid (TNB) on colonocyte arachidonic acid metabolism. J Surg Res. 1996 Feb 1;60(2):375–378. doi: 10.1006/jsre.1996.0061. [DOI] [PubMed] [Google Scholar]
  18. Tsuji S., Kawano S., Sawaoka H., Takei Y., Kobayashi I., Nagano K., Fusamoto H., Kamada T. Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot Essent Fatty Acids. 1996 Sep;55(3):179–183. doi: 10.1016/s0952-3278(96)90095-2. [DOI] [PubMed] [Google Scholar]
  19. Viganò T., Habib A., Hernandez A., Bonazzi A., Boraschi D., Lebret M., Cassina E., Maclouf J., Sala A., Folco G. Cyclooxygenase-2 and synthesis of PGE2 in human bronchial smooth-muscle cells. Am J Respir Crit Care Med. 1997 Mar;155(3):864–868. doi: 10.1164/ajrccm.155.3.9117018. [DOI] [PubMed] [Google Scholar]
  20. Wu K. K. Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol. 1995;33:179–207. doi: 10.1016/s1054-3589(08)60669-9. [DOI] [PubMed] [Google Scholar]
  21. Yang V. W. Eicosanoids and inflammatory bowel disease. Gastroenterol Clin North Am. 1996 Jun;25(2):317–332. doi: 10.1016/s0889-8553(05)70249-1. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES